Michael V. McConnell, MD, MSEE
Publication Details
-
Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk.
Am J Cardiol. 1997; (9): 1226-8
There is substantial epidemiologic data, but limited experimental data, supporting the mortality benefit of low-dose alcohol consumption. A regimen of a single, daily alcoholic beverage was sufficient to increase both high-density lipoprotein (HDL) (4.4%, p = 0.03) and HDL2 (7.7%, p = 0.04) in men and women, but did not significantly affect hemostatic markers of cardiovascular risk.
Help